Uncategorized - March 4, 2014
New discovery on anti-inflammatory substance
There is once again hope of a new anti-inflammatory drug based on the principal of blocking LTA4 hydrolase. There have been great expectations regarding the production of a drug to block the enzyme LTA4 hydrolase, which plays a key role in the body’s inflammatory response. However, in clinical trials, such molecules have proven to be […]
Pharma Business - March 4, 2014
AstraZeneca’s Delaware facilities sold
JPMorgan has bought half of AstraZeneca’s research campus in Delaware for $44 million. The 58-acre site forms the southern wing of AstraZeneca’s Wilmington-based American headquarters, and the drugmaker plans to vacate the site by year’s end, according to the Philadelphia Business Journal. The south campus was previously home to AstraZeneca’s Global Medicines Development unit. The […]
Uncategorized - March 3, 2014
New blood screen can reveal risk of dying
Researchers from Finland and Estonia have identified four biomarkers that help to identify people at high risk of dying from any disease within the next five years. The researchers screened blood samples from over 17 000 generally healthy people for more than a hundred different biomolecules. The health status of these study volunteers was followed for […]
Drug Development Pharma - March 3, 2014
Green light for AstraZeneca’s Bydureon Pen
The FDA has approved the Bydureon Pen as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes. The pen is a pre-filled, single-use pen injector, eliminating the need for the patient to transfer the medication between a vial and syringe during the self-injection process. It contains the same formulation and […]
Drug Development Pharma - February 28, 2014
Oasmia gets FDA approval for veterinary drug
The U.S. Food and Drug Administration (FDA) has conditionally approved the Swedish pharmaceutical company’s product Paccal. Paccal Vet-CA1 is the first veterinary drug to utilize paclitaxel, a frequently used chemotherapeutics for the treatment of a wide range of cancers in humans. Paccal Vet-CA1 is specifically formulated for use in dogs for the treatment of canine skin and mammary cancers. […]
Drug Development Pharma - February 28, 2014
Automated dispensing of medicines introduced at Kuopio University Hospital
Etteplan is designing an new medical automation system for Newico for tracking a pharmaceutical product all the way from the factory to the patient. The first part of the system will be introduced at Kuopio University Hospital in Finland in 2015. Kuopio University Hospital has placed an order with Newico for an automation solution for […]
